6:00 PM
Sep 25, 2012
 |  BC Extra  |  Company News

FDA grants Priority Review to Amitiza sNDA

Sucampo Pharmaceuticals Inc. (NASDAQ:SCMP) and Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) announced late Tuesday that FDA granted Priority Review to an sNDA for...

Read the full 99 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >